Personalized therapies begin with genomic profiling of the patient's tumor. This process involves sequencing the DNA of cancer cells to identify specific mutations and molecular alterations that drive the cancer's growth. Based on this information, oncologists can select targeted therapies that specifically address these unique characteristics.
